PCR-based technologies form the basis for rapid identification and quantification of pathogens. Our focus is on the development of multiplex PCR systems for highly parallel detection of pathogens.
On their basis, methods for the diagnosis of viruses, fungi, protozoa and bacteria can be developed for customers from companies, hospitals and research institutions.
Using PCR-based technologies, the smallest amounts of nucleic acids can be amplified in a highly specific manner. This forms the basis for rapid, sensitive identification and quantification of pathogens.
NALFA – Rapid diagnosis of pathogenic viruses
Lateral flow assays (LFA) are rapid medical tests that can be used regardless of location and equipment. For the detection of Herpes simplex virus 1 we were able to demonstrate a nucleic acid-based LFA. This enables rapid on-site diagnostics (point-of-care test) to identify the infectious agent. The test can also be further developed for diagnosis of the novel coronavirus SARS-CoV-2.